and specifi city of ASDAS cut-off values for disease activity states

and specifi city of ASDAS cut-off values for disease activity states

Achievement of Remission Endpoints with Secukinumab Over 3 Years in Active Ankylosing Spondylitis: Pooled Analysis of Two Phase 3 Studies

JCM, Free Full-Text

Achievement of Remission Endpoints with Secukinumab Over 3 Years in Active Ankylosing Spondylitis: Pooled Analysis of Two Phase 3 Studies

Statistical measures of agreement between BASDAI and ASDAS- ESR

and specifi city of ASDAS cut-off values for disease activity states

Disease activity state by ASDAS-CRP vs. ASDAS-qCRP (A) and ASDAS-CRP

Assessment and Monitoring, Ankylosing Spondylitis

Table 1 from ASAS40 and ASDAS clinical responses in the ABILITY-1 clinical trial translate to meaningful improvements in physical function, health-related quality of life and work productivity in patients with non-radiographic axial